| AGVEX | CWICX | AGVEX / CWICX | |
| Total Expense Ratio | 0.82 | 1.52 | 54% |
| Annual Report Gross Expense Ratio | 0.82 | 1.52 | 54% |
| Fund Existence | 7 years | 24 years | - |
| Gain YTD | 10.177 | 13.758 | 74% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.5B | 160B | 13% |
| Annual Yield % from dividends | 0.71 | 0.66 | 109% |
| Returns for 1 year | 19.41 | 14.79 | 131% |
| Returns for 3 years | 56.70 | 44.86 | 126% |
| Returns for 5 years | 52.73 | 30.00 | 176% |
| Returns for 10 years | N/A | 104.70 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FRBRX | 218.09 | 5.52 | +2.60% |
| Franklin Biotechnology Discovery R6 | |||
| VEUSX | 111.82 | 2.10 | +1.91% |
| Vanguard European Stock Admiral | |||
| GSIKX | 25.45 | 0.40 | +1.60% |
| Goldman Sachs International Eq Inc Instl | |||
| MUOAX | 34.91 | -0.03 | -0.09% |
| Morgan Stanley Instl US Core A | |||
| BUFMX | 14.26 | -0.24 | -1.66% |
| Buffalo Mid Cap Growth | |||